Evidence map›Paper›PMID 39975741›Full record

ArticleJournal of thoracic disease2025

T4-non-small cell lung cancer invading the thoracic aorta: the role of the hybrid operating room.

Francesco Zaraca, Marco Damiano Pipitone, Giovanni Coppi, Birgit Feil, Luiz Felippe Milazzo, Giovanni Zaraca, Reinhold Perkmann, Andreas Kirschbaum, Claudia Bardoni, Luca Bertolaccini

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francesco ZaracaDepartment of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.ORCID https://orcid.org/0000-0003-4846-2469
Marco Damiano Pipitone *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Giovanni Coppi *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Birgit Feil *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Luiz Felippe Milazzo *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Giovanni Zaraca *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Reinhold Perkmann *Department of Vascular and Thoracic Surgery, Bolzano Central Hospital, Bolzano, Italy.
Andreas Kirschbaum *Department of Visceral, Thoracic and Vascular Surgery, University of Marburg, Marburg, Germany.
Claudia Bardoni *Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Luca BertolacciniDepartment of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced non-small cell lung cancer (NSCLC) management has become profoundly linked to disease stage and molecular profile. Targeted therapies and immunotherapy have refined treatment options. Developments in minimally invasive surgery and endovascular techniques necessitate reevaluation of T4-NSCLC resectability, especially for T4-NSCLC that invades the thoracic aorta (T4invAo). In cases of suspected aortic invasion in anticipation of surgery, a three-dimensional computed tomography (3D CT) reconstruction is indicated to define the size of the thoracic endoprosthesis that could be used if invasion is confirmed. Preoperative planning meticulously determines the proximal and distal landing zones for the endograft. This crucial step involves carefully considering two key factors: (I) the length of the aortic segment requiring surgical resection during the concomitant thoracic surgical procedure to achieve oncological radicality. This resection encompasses the tumor-infiltrated aortic segment and an additional 2 cm proximal and distal disease-free margin. (II) Further proximal and distal 2-3 cm of the aorta must be added to the planning to ensure adequate endograft apposition to the aortic wall. We propose performing these procedures in a hybrid operating room (HOR) equipped with a C-arm robotic system. In the HOR, the first step involves a video-assisted thoracoscopic surgery diagnostic procedure to confirm the preoperative suspicion of aortic wall invasion. If confirmed, the second step utilizes HOR to place a thoracic endoprosthesis to cover the infiltrated aortic segment. Following patient positioning, image fusion is performed. The preoperative CT reconstruction is matched to these two-dimensional (2D) fluoroscopic images using bony landmarks for real-time 2D-3D image fusion that allows the visualization of the 3D reconstruction overlaid on the live fluoroscopy. Following image fusion, aortography is performed. The stent graft is deployed using standard techniques, with the aid of the fusion image. Following stent-graft deployment, aortography confirms the patency of the side vessels. The third step concludes with

Indexed as

aortic invasionhybrid operating room (HOR)Locally advanced non-small cell lung cancer (locally advanced NSCLC)thoracic endovascular aortic repair (TEVAR)

Identifiers

PMID39975741
PMCPMC11833570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.